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Abstract
The rational design of amyloid oligomer inhibitors is yet an unmet drug development need. Previous studies have identified
the role of tryptophan in amyloid recognition, association and inhibition. Furthermore, tryptophan was ranked as the
residue with highest amyloidogenic propensity. Other studies have demonstrated that quinones, specifically
anthraquinones, can serve as aggregation inhibitors probably due to the dipole interaction of the quinonic ring with
aromatic recognition sites within the amyloidogenic proteins. Here, using in vitro, in vivo and in silico tools we describe the
synthesis and functional characterization of a rationally designed inhibitor of the Alzheimer’s disease-associated b-amyloid.
This compound, 1,4-naphthoquinon-2-yl-L-tryptophan (NQTrp), combines the recognition capacities of both quinone and
tryptophan moieties and completely inhibited Ab oligomerization and fibrillization, as well as the cytotoxic effect of Ab
oligomers towards cultured neuronal cell line. Furthermore, when fed to transgenic Alzheimer’s disease Drosophila model it
prolonged their life span and completely abolished their defective locomotion. Analysis of the brains of these flies showed a
significant reduction in oligomeric species of Ab while immuno-staining of the 3rd instar larval brains showed a significant
reduction in Ab accumulation. Computational studies, as well as NMR and CD spectroscopy provide mechanistic insight into
the activity of the compound which is most likely mediated by clamping of the aromatic recognition interface in the central
segment of Ab. Our results demonstrate that interfering with the aromatic core of amyloidogenic peptides is a promising
approach for inhibiting various pathogenic species associated with amyloidogenic diseases. The compound NQTrp can
serve as a lead for developing a new class of disease modifying drugs for Alzheimer’s disease.
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Introduction
Alzheimer’s disease (AD), a progressive neurodegenerative
disorder for which there is no cure or effective treatment, is the
leading cause of dementia in aged humans. Symptoms include
memory loss, confusion, impaired judgment, personality changes,
disorientation and loss of language skills [1,2]. The major
neuropathological changes in the brains of AD patients include
neuronal death, particularly in regions related to memory and
cognition and the presence of intra- and extra-cellular abnormal
protein aggregates [3,4] known as neurofibrillary tangles and
amyloid plaques, respectively. In the past several years a large
body of evidence has established a pathological role for b-amyloid
polypeptide (Ab) in AD [5–10]. Accumulating evidence indicate a
fundamental role of the early soluble oligomeric species of Ab,
rather than the mature fibrillar species, in the pathogenesis of AD
[11–15]. Yet, the molecular mechanism underlying the assembly
of the different Ab species is not fully understood. However, since
these structures self-assemble, from monomers to higher oligo-
meric or fibrillar structures in a highly ordered and efficient
manner, it is likely that specific recognition elements mediate the
process.
We and others have identified a central role of aromatic residues
in formation and stabilization of amyloid structures [16–19]. This
notion has gained direct evidence by high-resolution structural
studies [20,21], theoretical analysis and molecular dynamics
simulations [22–25]. Among the aromatic moieties, tryptophan
was ranked as the residue with highest amyloidogenic potential by
Dobson and co-workers [26] and an un-biased analysis, using
peptide array technology, has clearly indicated a significantly
higher affinity of tryptophan-modified recognition module in the
molecular association of the islet amyloid polypeptide [27].
Indeed, as expected from these findings, several small aromatic
molecules such as polyphenols [28–30] and small aromatic
peptides [31] were shown to inhibit the aggregation of several
amyloidogenic peptides. Furthermore, we have shown significant
inhibition in vitro of the Ab polypeptide by indole derivatives [32].
Moreover, we have recently demonstrated efficient inhibition of
Ab oligomerization by a short D-tryptophan-Aib dipeptide both in
vitro and in vivo [31], further underscoring the important role of
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tryptophan in the binding and inhibition of Ab. These findings
have led to the suggestion that targeting of aromatic recognition
interfaces by tryptophan could be a useful strategy for anti-
amyloid formation.
Quinones have long been known to act as inhibitors of various
metabolic pathways in the cell, to have anti-bacterial, anti-viral,
and also anti-cancer activities [33,34]. Several quinones have been
shown to be effective inhibitors of the aggregation of several
amyloidogenic proteins. For example, p-benzoquinone was
reported to reduce the toxicity of islet amyloid peptide aggregates
[35] and inhibit amyloid fibril formation by hen egg-white
lysozymes [36]. Likewise, anthraquinones were demonstrated to
be effective inhibitors of Tau protein aggregation [37]. Recently,
1,2-naphthoquinone was shown to effectively inhibit Ab42
oligomerization in vitro [38]. It appears that the asymmetric dipole
of the quinonic ring plays a central role in the interaction between
the molecule and the amyloidogenic peptides. The interactions at
the basis of the anti-amyloid activity of anthraquinone (a tri-cyclic
quinone) were recently shown to be the hydrogen bonds, the
aromatic contacts and, moreover, the ability to establish a
favorable interaction between the central electron-poor quinonic
ring and the electron-rich peptidic carbonyls [39].
Here we sought to combine the strong interaction and
recognition between tryptophan and the Ab peptide with the
documented inhibitory capability of quinones towards Ab
assembly. To that end we examined the effect of 12 different
hybrid molecules, consisting of a naphthoquinone and different
linked residues, towards Ab oligomerization and fibrillization.
Among the compounds tested the hybrid 1,4-naphthoquinon-2-yl-
L-tryptophan (termed hereafter NQTrp) [40] was found to be the
most effective.
We hypothesize that intermolecular alignment of the phenyl-
alanine (at position 19 or 20 of the Ab sequence) intercalated
between the flat electron-deficient naphthoquinone moiety and the
high electron-dense indole ring of the tryptophan, would lead to
formation of a near face-to-face stable complex. Due to near face-
to-face and edge-to-face geometry accompanied by sterical
hindrance, the intermolecular complex of the aromatic elements
effectively prevents Ab assembly. Structural analysis supports this
proposed mode of action of NQTrp. In vivo assays demonstrate
that Ab inhibition is accompanied by significant amelioration of
AD-engendered symptoms.
Results
Twelve naphthoquinone hybrid molecules were screened for
their ability to inhibit formation of Ab oligomers and fibrils in vitro
[Figure S1, Table S1]. All twelve molecules included a 1,4-
naphthoquinone, but with different residues linked to it, some
aromatic and some not. All hybrid molecules were analyzed both in
the oligomer inhibition assay and ThT fibril inhibition assay
described below for NQTrp, followed by TEM analysis (not shown).
Results of all hybrids are summed up in Table S1. They show that
NQTrp had strongest inhibition activity, towards the formation of
both Ab oligomers and fibrils. It is also apparent that both the D
isomer of NQTrp (compound IID in Table S2) and the indole
derivative (compound III) are good inhibitors. These results strongly
suggest that the linking between 1,4-naphthoquinone and a
molecule containing an indole ring is crucial for optimal inhibition.
Inhibition of toxic Ab oligomer species
The effect of NQTrp on the ability of early non-toxic
intermediate Ab oligomers (,18 kDa) to further grow into the
toxic dodecameric oligomer assemblies (,56 kDa) was analyzed
using the protocol established by Hillen and coworkers [15]. This
protocol results in the formation of SDS-stable oligomers that
display toxic effects on the long-term potentiation of cultured
neural cells [15]. For example, to evaluate the effect of NQTrp
(Figure 1A) on the transformation of the Ab into the toxic
assemblies, the inhibitor was incubated with Ab1–42 at increasing
molar ratios, and the reaction mixtures were resolved on SDS-
PAGE (Figure 1B). The results reveal dose-dependent inhibition,
by NQTrp, of the ability of Ab to assemble into toxic oligomers
(,56 kDa), inhibition was apparent at a low 5:1 (Ab1–42:NQTrp);
Figure 1. Inhibition of Ab oligomer formation in vitro. A.
Structure of 1,4-naphthoquinon-2-yl-L-tryptophan (NQTrp). B. Determi-
nation of the dose-dependent effect of NQTrp on soluble oligomer
formation. Soluble oligomers were prepared according to the method
of Barghorn et al. [15] with and without increasing concentration of
NQTrp. Ab concentration was set at 133 mM. Molar ratios of Ab:NQTrp
are indicated. The control is Ab only. C. The affinity of NQTrp towards
early oligomers was determined using fluorescence anisotropy.
doi:10.1371/journal.pone.0011101.g001
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however the inhibition profile is non linear. The decreased
inhibition effect at mid-range molar rations such as at a 1:1 ratio
may be due to a competing homomolecular noncovalent
interaction as observed for various other small molecular inhibitors
such as indole moieties and small peptides. The inhibitor appears
to stabilize the non-toxic early oligomers and inhibit their further
growth into toxic species. Complete inhibition was seen only at
molar excess of NQTrp.
Characterization of the interaction between NQTrp and
Ab
The affinity of NQTrp towards the early Ab1–42 assemblies was
demonstrated using fluorescence anisotropy assay, taking advan-
tage of the intrinsic fluorescence of the Trp-substituted quinone
and its relatively small size as compared to the Ab oligomers.
Increasing amounts of early assemblies of Ab were titrated into a
solution of NQTrp and anisotropy was determined (Figure 1C).
The affinity constant of NQTrp was estimated to be 90 nM.
Inhibition of amyloid fibril formation by NQTrp
The relative contribution of Ab fibrils versus oligomers to the
pathogenesis of AD has not been completely resolved [41]. We
therefore wanted to discern whether or not NQTrp also inhibits
the formation of mature b-amyloid fibrils. To that end we used the
Thioflavin-T (ThT) binding assay, which provides a quantitative
measure of amyloid fibril formation. Ab1–40 was allowed to form
amyloid fibrils either in the absence or in the presence of
increasing concentrations of NQTrp (Figure 2A). The process of
fibrillization was followed for several days until a plateau was
reached and its kinetics was measured. The formation of Ab fibrils
was significantly reduced in the presence of the inhibitor, even at
low molar ratios of 4:1 (Ab1–40:NQTrp). This is especially evident
after 270 hours (Figure 2B). A similar experiment using Ab1–42
resulted in IC50 of 50 nM (Figure 2E). These results clearly
indicate that the NQTrp is an effective inhibitor of Ab fibril
formation.
The morphology of the Ab fibrils formed during the course of
fibrillization was compared, in the presence and in the absence of
NQTrp, using transmission electron microscopy (TEM). Samples
were taken from the amyloid fibril formation experiment after 7
days of incubation. The fibrils formed by Ab alone were large,
broad and ribbon-like (Figure 2C). The samples containing Ab
and NQTrp showed drastic reduction of fibrils. The few fibrils that
formed in the presence of the inhibitor were much thinner and
Figure 2. Inhibition of Ab fibril formation in vitro. A. Dose dependent kinetic analysis of the inhibition of NQTrp towards fibril formation of Ab1–42
over the course of 270 hours. Ab concentration was set to 5mM. Concentrations are expressed as Ab:quinone molar ratio: Control - Ab1–42 only (¤), 1:5
(&), 1:1 (m), 2:1 (N), 4:1 (*). (CPS = Counts Per Second) B. Endpoint of ThT analysis after 270 hours. C–D. Transmission Electron Microscope images taken
from ThT analysis after 270 hours. Ab1–42 alone (C), Ab1–42 with NQTrp (1:5) (D). E. Dose dependent inhibition by NQTrp of the fibrillization of Ab1–42 (ThT
assay). Concentration of Ab1–42 was set to 5uM. Control - Ab1–42 alone. An IC50 of 50nM was calculated.
doi:10.1371/journal.pone.0011101.g002
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shorter (Figure 2D). This strongly correlated with the values
observed in the amyloid fibril formation experiment.
NMR analysis of the interaction of NQTrp with Ab
To characterize the precise interaction between NQTrp and
Ab, NMR analysis was conducted. NQTrp was incubated with a
truncated fragment of Ab, Ab12–28, which is a less-aggregative
fragment, commonly used to avoid complications of oligomeriza-
tion and fibrillization during the NMR process. Ab residues 16–22
have been shown to participate in the transition into the b-sheet
secondary structure and are independently capable of forming
amyloid fibrils [42–44]. Furthermore, this short fragment of Ab
contains the central aromatic recognition motif of the polypeptide
[44].
NQTrp was titrated into Ab12–28 sample in 10 mL aliquots, in
the same solvent batch as the peptide samples, to achieve
increments of 0.11 mM of NQTrp per aliquot. After each
addition, the 1H-NMR spectrum was taken. The addition of
NQTrp to Ab12–28 in solution affected the backbone amide
chemical shifts of the peptide (Figure 3A). Changes in chemical
shift at a 2:1 molar ratio (Ab12–28:NQTrp) were compared to the
average change in chemical shift of 0.1 Hz when a 0.1 mM
aliquot of NQTrp was added as a control. These were most
evident in residues Phe20, Ala21 and Glu22, which showed
changes of 8, 5 and 3 Hz, respectively. Both Val18 and Val24, also
showed a lesser change in chemical shift of 2 Hz. Non-terminal
residues that were unaffected by the addition of NQTrp showed
mostly chemical shift deviations of less than 1 Hz. The NMR
Figure 3. NMR analysis of Ab with NQTrp. A. Amide proton chemical shifts deviations of Ab12–28 residues upon interacting with NQTrp at molar
ratio between 1:0.1 and 1:0.5 (Ab12–28:NQTrp). *Residues Lys16 and Gly25 were unresolved. B. NOE connectivity plot: NOE interactions are
proportional to the thickness of the interconnecting lines. C. Lowest energy structure generated for Ab12–28 with NQTrp (at 4:1 molar ratio). Ensemble
of 28 from 50 starting structures had a RMSD of 2.28 A˚ overall and 0.71 A˚ and 0.74 A˚ in regions 16–20 and 22–26. Residues that showed significant
deviations upon binding NQTrp are colored in green. The positive (blue) and negative (red) electrostatic potential distribution for62 kT/e is mapped
onto the structure. D. Secondary structure statistics: percentage of low energy structures in turn (black), bend (grey) or coil (white), secondary
structures.
doi:10.1371/journal.pone.0011101.g003
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experiments of NQTrp-Ab12–28 binding thus showed the most
prominent interactions in the region of Phe20 to Glu22. The
changes in chemical shift indicate altered chemical environment
either due to a direct interaction with NQTrp itself or due to a
structural change that occurs upon binding.
The structure of Ab12–28 was solved in the presence of 0.25
molar ratio of NQTrp to Ab (Table 1 and Figure 3B). The
spectrum was resolved and showed numerous interactions (Table 2,
Table S2, Figure S2 and S3). Of the 50 calculated structures
(RMSD 2.37 A˚ on the backbone), 28 had no violations and a
RMSD value of 2.28 A˚ and 9 low-energy structures were chosen
for structural analysis. (Figure S3, backbone (bb) RMSD 1.12 A˚).
These had three regions of stability (Figure 3D): Residues 14–16
(bb RMSD 0.71 A˚) showed a number of NOE interactions
between the region of His13 and His14 and Leu17; residues18–20
showed a turn including phenylalanines 19 and 20 (bb RMSD
0.12 A˚). The general structure of the ensemble showed a loose b-
hairpin with a turn at residues18–20 including phenylalanines 19
and 20 (bb RMSD 0.12 A˚). Additional regions of stability
(Figure 3D) included residues 14–16 (bb RMSD 0.71 A˚) that
showed a number of NOE interactions between the region of
His13 and His14 and Leu17; and a turn at residues 22–26 (bb
RMSD 0.0.67 A˚) that were stabilized by hydrogen bonding
between the amide proton of Ser26 and the backbone oxygen of
Asp23 in the majority of the conformations. This turn was
unexpected and may either be an artifact of working with a
truncated peptide, or part of the mechanism by which NQTrp
disrupts plaque accumulation.
Figure 3C shows the lowest calculated energy conformation
with residues Val18, Phe20, Ala21, Glu22 and Val24, colored in
green to indicate residues whose chemical shift changed upon
interacting with NQTrp. The positive (blue) and negative (red)
electrostatic potential distribution for62 kT/e is mapped onto the
structure; showing the positively charged N-terminus and Lys28,
and the negative potential in the central region of the Ab12–28
peptide.
CD characterization of the interaction of NQTrp with Ab
Samples containing Ab1–42 and NQTrp were subsequently
analyzed by Circular Dichroism (CD) to gain information on the
secondary structural changes that the early Ab species undergo
when incubated with NQTrp. Native Ab1–42 oligomers exhibit a
strong positive band around 195 nm and a negative band at
217 nm, indicating a b-sheet conformation. A dose dependent
decrease in both of these bands and a small shift in the spectrum
were evident with increasing concentrations of NQTrp, yet the
typical b-sheet spectrum is still apparent (Figure 4). This implies
that, when incubated with NQTrp, Ab retains its b-sheet
conformation, yet this conformation is gradually lost with
increasing concentrations of the naphthoquinone.
Simulation of Ab assembly with and without NQTrp
Computer simulations were carried out to further investigate the
interactions between NQTrp and Ab. We examined the influence
of NQTrp on the early phase of ordered aggregation of the central
region of the Ab peptide, focusing on the segment 14–24, centered
on Phe 19 and Phe 20. A divide-and-conquer approach [46] has
Table 1. 1H chemical shift assignment of Ab12-28.
HN Ha Hb Others
V12 3.72 2.10 CH3 c 0.89
H13 8.89 4.66 3.15 Hd2 7.24, He1 8.55
H14 8.73 4.66 3.18, 3.06 Hd1 8.49, Hd2 7.26, He1 8.56
Q15 8.59 4.28 2.02, 1.94 CH2 c 2.32, He 7.6, 6.95
K16 8.48 4.24 1.76, 1.71 CH2 c 1.41, 1.34, CH2 d 1.64, CH2 e 2.93
L17 8.32 4.31 1.56, 1.42 CH c 1.56, CH3 d 0.89, 0.82
V18 7.96 4.01 1.88 CH3 c 0.79, 0.72
F19 8.21 4.54 2.96, 2.85 CH2 d 7.30, He7.28, Hf7.14
F20 8.14 4.54 3.09, 2.93 CH2 d 7.33, He7.31, Hf7.22
A21 8.26 4.19 1.33
E22 8.28 4.24 2.04, 1.91 CH2 c 2.35
D23 8.39 4.65 2.78, 2.67
V24 8.07 4.11 2.14 CH3 c 0.92, 0.91
G25 8.50 3.94
S26 8.13 4.42 3.84
N27 8.45 4.70 2.80, 2.73 CH2 d 7.61
K28 7.87 4.13 1.80, 1.67 CH2 c 1.35, CH2 d 1.62, CH2 e 2.96, Hf2 7.54
NQTrp 7.04 4.23 3.51, 3.26 CH2 d 7.26, He1 10.18, He3 7.63, Hg1 7.13,
doi:10.1371/journal.pone.0011101.t001
Table 2. NOE interaction statistics.
Total number of restraints 177
Intra-residual restraints 52
i+1 restraints 74
i+2 restraints 25
i+3 restraints 18
Long range restraints 8
doi:10.1371/journal.pone.0011101.t002
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been adopted to efficiently sample the conformational transitions
of the system. Therefore, the segment was decomposed into three
overlapping heptapeptides: Ab14–20, Ab16–22, and Ab18–24 (see
sequences in Table S3). Implicit solvent molecular dynamics (MD)
simulations were used to simulate the aggregation of three replicas
of the considered peptides in presence and absence of NQTrp.
During the simulations the three-peptide system explores several
configurations. The P2 order parameter (described in Materials
and Methods) has been adopted to monitor the degree of
orientational order within the oligomers: a value close to one
corresponds to an ordered trimer, with either parallel or
antiparallel b-sheet, while a value close to zero reflects a fully
disordered system. The frequency histograms of P2 for the
unperturbed and perturbed systems (Figure 5) display a prominent
peak at P2 = 0.8, and a shoulder for P2 values lower than 0.5,
which includes disordered aggregates and isolated peptides. The
Figure 4. CD studies of Ab with NQTrp. CD spectrum of Ab1–42. Concentration indicated as Ab:NQTrp molar ratio. Control - Ab1–42 only (black),
1:60 (grey), 1:30 (blue), 1:1 (orange), 5:1 (red).
doi:10.1371/journal.pone.0011101.g004
Figure 5. NQTrp hinders b-sheet formation. Red lines and black lines correspond to simulations with and without NQTrp, respectively. (Top)
Frequency histograms of the nematic order parameter P2 for the three Ab segments. Values of P2 close to 0.2 and 0.8 correspond to disordered
conformations and b-sheet structures, respectively (see the insets in the top right plot). The presence of NQTrp sensibly increases the amount of
disordered structures for all peptides. (Bottom) Inter-peptide interaction energy distributions. The two peaks of the distributions correspond to a
peptide in the center of an ordered oligomer (about 280 kcal/mol) and a peptide at the edge of an ordered oligomer (about 240 kcal/mol). The
shoulder of the energy distribution at values of about 220 kcal/mol contains events with disordered or partially ordered oligomers (see insets in the
bottom right plot). NQTrp markedly increases the amount of structures with unfavorable inter-peptide interaction energy.
doi:10.1371/journal.pone.0011101.g005
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threshold value P2
* = 0.665 is chosen as the crossover between
ordered and disordered states (see Materials and Methods) [39].
The ratio between order and disorder clearly shows that NQTrp
perturbs the order of the aggregate (Table S3) by increasing the
population of disordered conformations for all three peptides. The
frequency distribution of inter-peptide interaction energies
(Figure 5) shows two peaks. The peak at 280 kcal/mol and the
peak at240 kcal/mol correspond to a peptide interacting with the
center and at the edge of an ordered trimer, respectively. From the
plots it is evident that the presence of NQTrp increases the
number of events with interaction energy close to zero, originating
from unstructured peptides bound to the oligomeric or isolated Ab
species. The presence of NQTrp alters the number of backbone
hydrogen bonds by increasing the intra-chain and decreasing the
inter-chain interactions (Table S3). The simulation results indicate
that the trimer structure is perturbed by NQTrp, which is able to
intercalate into the oligomer and influence its structure, supporting
the evidence attained above by NMR and CD spectroscopy.
Binding mechanism of NQTrp to Ab by computational
analysis
Further computational analysis was conducted in order to
determine the binding mechanism of NQTrp to Ab. Hereafter,
the hydrogen bonds between NQTrp and the Ab peptide backbone
will be identified using the labels of polar groups of NQTrp (see inset
of Figure 6 for the labels), e.g., NH1-CO is the hydrogen bond
between NH1 group and any carbonyl group of the backbone.
Furthermore the interaction with a certain residue will be specified
with the amino acid name, e.g., NH1-Phe20 is the hydrogen bond
between NH1 group and backbone carbonyl of Phe20, and CO1-
Phe20 is the hydrogen bond between CO1 group and Phe20
backbone amide. Due to the symmetry of the carboxyl oxygens of
NQTrp, the hydrogen bond that can be formed with one of the two
CO moieties will be referred as to CO3-NH. The frequency of
hydrogen bond formation between the carbonyl groups of NQTrp
and the amide backbone is shown in Figure 6. The agreement with
the NMR amide proton chemical shift deviations is remarkable.
The backbone amides that interact most with NQTrp through
hydrogen bonds belong to Phe20, Ala21, and Glu22. It is worth
noting that, although the van der Waals interaction energies
between NQTrp and Phe19 or Phe20 are very similar, there is a
much higher propensity for NQTrp to form a hydrogen bond with
Phe20. The most frequent hydrogen bonds involving the peptide
backbone are NH1-CO, CO1-NH and CO3-NH (Figure S4, Table
S4). Interestingly, the hydrogen bond pairs NH1-CO, with CO1-
NH or CO3-NH occur simultaneously at high probability (about
10% of the trajectory), and very frequently the three hydrogen
bonds are formed at the same time (5% of the trajectory) (Table S5).
These hydrogen bonds occur either within the same residue (Phe20
or Ala21), or within two amino acids that are separated by a single
residue (Val18, Phe20, or Phe20, Glu22) (Table S5).
Notably, the MD simulations show that NQTrp strongly perturbs
the ordered aggregation of the Ab peptides by binding with specific
hydrogen bonds and aromatic interactions. The snapshots shown in
Figure 7 were extracted from the trajectories according to the most
frequent hydrogen bond pairs (See Methods). In the most frequent
binding patterns, NQTrp has a closed conformation in which the
indole and the naphthoquinone ‘‘clamp’’ the phenyl rings of Phe19 or
Phe20 (Figures 7A–C). In addition, there are stable hydrogen bonds:
CO1-Ala21, and NH1-Ala21 (Figures 7A and B), or CO1-Phe20,
Figure 6. Computer analysis of the interactions between
NQTrp and Ab. Frequency of interactions between all NQTrp CO
groups and peptide backbone NHs (left y-axis). Open symbols
correspond to residues proximal to the N-terminal or C-terminal of
the peptide (positions 1, 2, 6, and 7 in each heptapeptide). Closed
symbols correspond to the central residues (positions 3, 4, and 5).
Average van der Waals interaction energy between the residues and
NQTrp are shown by blue triangles (right y-axis). Lower values
correspond to more favorable interaction energy.
doi:10.1371/journal.pone.0011101.g006
Figure 7. Modeling of representative snapshots of the binding
modes of NQTrp to the Ab_peptide. (A,B) The two most frequent
conformations (12% and 9%) when NQTrp is bound to Ab18–24
through CO1-NH and NH1-CO interactions with Ala21. The main
difference between the two structures is the swap of Phe20 and Phe19
as a counterpart for aromatic interactions with NQTrp. C The most
frequent conformation (17%) obtained when NQTrp is bound to Ab18–
24 and is involved in CO1-NH and NH1-CO interactions with Phe20. To
emphasize the aromatic interactions of the naphthoquinone and the
indole moieties of NQTrp with the phenyl ring of Phe19, a lateral view
of the conformation c. is shown in the inset. D The most frequent
conformation (11%) when NQTrp is bound to Ab16–22 through CO1-
NH with Phe20 and NH1-CO with Val18. Here the indole of NQTrp
interacts with Val18, and naphthoquinone with Phe19. See inset of Fig. 5
for the labeling of the polar groups.
doi:10.1371/journal.pone.0011101.g007
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NH1-Phe20 and CO3-Glu22 (Figure 7C). In this case Phe19
interacts with both aromatic groups of NQTrp as well. Conversely, in
the presence of the NH1-Val18 and CO1-Phe20 hydrogen bonds,
the indole and naphthoquinone moieties do not act as ‘‘clamp’’ but
rather interact with the Val18 and Phe19 side chains, respectively
(Figure 7D). Note that in all cases aromatic stacking and hydrogen
bonds with polar groups of the backbone are present.
NQTrp inhibits the cytotoxic effect of Ab towards
cultured cell line
To further substantiate the inhibition by NQTrp we tested
whether it affects the cytotoxicity of Ab1–42 oligomers towards the
rat PC12 neuronal cell line. Toxic Ab oligomers were incubated
with increasing concentrations of NQTrp and cell viability was
measured using the MTT assay. While showing no toxic effect of
its own towards cultured cells (Figure S5), NQTrp significantly
inhibited the cytotoxic effect of the Ab oligomers and caused a
significant dose dependent increase in the viability of the cells
(Figure 8A). This effect was most apparent at molar excess of
NQTrp which correlates with results attained from the inhibition
of toxic Ab oligomers analysis.
The effect of NQTrp in an in vivo transgenic fly system
In order to assess the effect of NQTrp on Ab in the living
organism, we used a Drosophila model of AD. Transgenic flies
expressing the human Ab1–42 protein in their nervous system, via
the Gal4-UAS system, display various symptoms reminiscent of
AD including defective locomotion, and memory, which deteri-
orate with age, as well as markedly reduced longevity. Their brains
display characteristic amyloid plaques and pathology [47].
Crossing male flies carrying the pan-neuronal elav-Gal4 driver (on
their X chromosome) with females homozygous for the autosomal
UAS-regulated Ab1–42 transgene, resulted in female offspring
expressing Ab1–42 in their nervous system. The male offspring carried
the Ab1–42 transgene but did not express it because they lacked the
Gal4 driver and served as control. This cross was performed either on
regular Drosophila medium or on medium supplemented with
0.75 mg/mL NQTrp. The animals fed on the appropriate medium
from the beginning of the larval stage onwards. Each class of adult
offspring was monitored daily for survival and locomotion (climbing).
Flies expressing the Ab1–42 transgene grown on regular medium
exhibited a significantly shorter life span than the control (male)
classes, as reported [47]. By day 16, only 50% of the flies expressing
the Ab1–42 transgene, were viable, while in the control class viability
was reduced to 50% only after 26 days. The life span of Ab1–42-
expressing flies reared on medium containing NQTrp (Figure 8B) was
much longer and was nearly identical to that of control flies grown on
regular medium (50% viability observed only at day 26). The
compound had no significant effect on longevity of the control flies.
Statistical analysis was performed using the SPSS 15 Kaplan-Meier
software package. Results show a significant difference between flies
(females) expressing the Ab1–42 transgene grown on regular medium
versus medium supplemented with NQTrp (P,0.0005). In contrast,
no significant difference was observed between Ab1–42-expressing flies
supplemented NQTrp and the control class grown on the same
medium (P.0.8). No significant difference was seen either between
the control class (males) grown on regular medium versus medium
supplemented NQTrp (P.0.5) (data not shown).
Ab1–42-expressing flies behaved normally at eclosion from the
pupal case and subsequently developed locomotion deficits as
reported [47–49]. At four days after eclosion these flies exhibited a
marked decrease (60%) in their climbing ability becoming almost
immobile by day 15, while the control classes were very active at
this time (Figure 8C). In contrast, Ab1–42-expressing flies reared on
Figure 8. NQTrp alleviates toxic effects of Ab – cell and fly
assays. A. The effect of NQTrp on cytotoxicity of soluble Ab oligmers.
Soluble oligomers were prepared with and without increasing concen-
trations of NQTrp. The cytotoxic effect of the preparations towards
cultured PC12 cells was determined using the MTT assay. Concentration
are indicated as Ab:NQTrp molar ratio. B. The effect of NQTrp on
longevity of Ab1–42-expressing flies. The life span of four classes of flies
was evaluated n = 60. Females expressing Ab1–42 grown on regular
medium (dotted line), females expressing Ab1–42 grown on medium
containing NQTrp (dashed line), males (control, carrying the Ab1–42
transgene but not expressing it) grown on medium containing NQTrp
males (control, carrying the Ab1–42 transgene but not expressing it)
grown on regular medium(not shown). C. The effect of NQTrp on
climbing behavior of Ab1–42-expressing flies.. Four classes, each
containing six vials with 10 flies in each: femalesexpressing Ab1–42
grown on regular medium (grey), females expressing Ab1–42 grown on
medium containing NQTrp (dashed line), males (control, carrying the
Ab1–42 transgene but not expressing it) grown on either regular medium
(white) or on medium containing NQTrp (black), were analyzed using the
climbing assay. Results show for each group the percent of flies climbing
to the top of the vial after 18 seconds, during the course of 14 days.
doi:10.1371/journal.pone.0011101.g008
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medium containing NQTrp displayed dramatic improvement,
behaving almost identical to the control classes (males reared on
medium lacking the compound) (Figure 8C). Importantly, no effect
of NQTrp was observed on locomotion of the control flies. One
tail ANOVA statistics showed P,0.0005 for all four classes.
To further assess the curative effect of NQTrp on AD flies, Ab
was extracted from fly brains over expressing the Arctic (Arc)
(E22G) mutant form of Ab, associated with increased aggregation
and early-onset familial AD [50]. These flies displayed short life
span and defective locomotion as reported [47] and both of these
defects were ameliorated by NQTrp as described above for Ab1–
42-expressing flies (data not shown). Aggregated forms of Ab were
readily detected in the soluble fraction of extracts from Abarc1-42-
expressing flies following immunoprecipitation with the 6E10 Ab-
specific antibody, followed by western blot. Using this procedure
monomers of Ab were detected in head extracts of both NQTrp-
fed and in non treated Abarc1-42-expressing flies. However, Ab
tetramers, which were evident in non treated Abarc1-42 flies [51],
were absent from extracts of flies fed with NQTrp (Figure 9A).
To evaluate the effect of NQTrp on Ab accumulation in the
brains of these flies, Abarc1-42 expressing larvae and adult flies, fed
or unfed with NQTrp, were immunostained with the 6E10
antibody. As reported [47,51], both the brains of untreated larvae
and adult flies displayed robust staining (Figure 9 D, E, 10 A–D)
representing accumulated Ab assemblies, not seen at all in brains
of control animals not expressing any Ab (Figure 9 A, B).
Importantly, brains of Abarc1-42-expressing animals that were fed
with NQTrp exhibited greatly reduced Ab staining. (Figure 9 F,
G, 10 E–H).
Taken together these results indicate that NQTrp reduced both
Ab oligomerization and accumulation in AD model flies.
Discussion
Our work provides a rational design route toward the
development of novel amyloid aggregation inhibitors of high
potency. The various levels of analysis indicate that indeed the
hybrid linking of naphthoquinone and tryptophan moieties leads
to a highly potent inhibitor of both the oligomerization and
fibrillization of Ab with a high affinity of 90 nM and an IC50 of
50 nM, which is markedly lower than that reported for other
aromatic Ab inhibitors (Table S6, Supp. references S1).
Our initial hypothesis that NQTrp should interact with the
central diphenylalanine recognition motif has gained direct
evidence by NMR spectroscopy and in silico analysis. The largest
chemical shift deviation was observed with Phe20 (8 Hz). A large
chemical shift deviation was also observed with Ala21 and Glu22,
5 and 3 Hz, respectively. These three sequential residues form a
turn in the NMR-derived conformers. The electrostatic potential
of the NMR conformers suggests that peptide association may be
mediated by electrostatic interactions among the distinct positive
and negative regions. Interactions between the Phe19-Phe20
aromatic side chains and NQTrp may interfere with peptide-
association.
This observation is further supported by the results of molecular
dynamics simulations which indicate that NQTrp is involved in
stable hydrogen bonds most frequently with the Phe20, Ala21 and
Glu22 backbone polar groups. Remarkably, both NMR spectros-
copy and computer simulations provide evidence that NQTrp
binds stronger to the backbone polar groups of Phe20 than Phe19,
as shown by the cluster representatives reported in Figure 7. The
van der Waals interaction analysis (Figure 6) revealed favourable
interaction energies between NQTrp and both the Phe19 and
Phe20 side chains. In fact, when NQTrp is involved in hydrogen
bonds with the backbone of the Phe20-Glu22 region, the
naphthoquinone and the indole ring are able to ‘‘clamp’’ the
phenyl ring of either Phe19 or Phe20, as shown in three of the four
most frequent binding modes (Figure 7). For geometrical reasons,
NQTrp does not frequently bind to the Phe19 backbone. As
revealed by visual inspection of the trajectories, in this conforma-
tion NQTrp ‘‘clamps’’ side chain of Val18 and the resulting
interaction is not favourable enough to stabilize this binding mode.
In addition to NQTrp a series of twelve quinone derivatives were
screened. The main result is that a hybrid between quinone and
indole is needed for optimal inhibition of both oligomerization and
fibril formation. As observed in the simulations, and in agreement
with the experimental inhibition assays, the presence of an electron-
deficient naphthoquinone moiety, together with the electron-dense
indole ring leads to the formation of a stable complex with the side
chains of Phe19 and Phe20. An essential element of the active
compounds (IL, IID, and III) is the presence of a three or four
rotatable bonds aliphatic linker between the two aromatic moieties.
Compounds with planar aromatic rings but devoid of the
aliphatic linker (molecules IV–XIII, Figure S1, Table S1) are more
rigid and for this structural reason their ability of inhibiting
oligomer formation is reduced.
Nevertheless, several of the molecules inactive against the
oligomers are still able to inhibit the fibril formation, probably
because of their ability to intercalate between the exposed side-
chains [52,53].
The main difference between IL, IID and III is the presence of a
negatively charged group (only in IL, IID) which can influence the
physical-chemical properties, e.g., the solubility and modify their ability
of interacting with oligomers or fibrils. In addition, the most frequent
hydrogen bonds with the peptide backbone of Ab involve the quinonic
carbonyls moieties, the anilinic nitrogen and the carboxyl group of
NQTrp (Figure S4, Tables S4 and S5). Taken together these
observations could explain the difference in activity of NQTrp and
its decarboxylated analogue (molecule III, Figure S1, Table S1).
CD analysis shows a reduction in b-sheet conformation when
increasing concentrations of NQTrp are titrated into the oligomeric
‘‘ordered’’ form of Ab. In silico analysis is in accordance with these
results (Figure 5). Molecular dynamics simulations revealed that
NQTrp destabilizes the inter-chain backbone hydrogen bonds and
increases considerably the structural disorder within the Ab
oligomer. Importantly, the inhibitory effects of the tryptophan-
modified naphthoquinone on Ab assembly in vitro correlate well with
its effects in vivo. NQTrp reduced the toxicity of Ab oligomers
towards cultured cells and completely alleviated Ab-engendered
symptoms in a transgenic fly model of AD, which correlated with
reduction of both Ab oligomerization (Figure 9A) and accumulation
of Ab in the brains of these animals (Figure 9 B–G, 10 A–H).
Taken together, the results presented here for a tryptophan-
modified naphthoquinone and our comparable results with D-
tryptophan-Aib dipeptides [31] indicate that the targeting of the
central recognition interface of Ab by structural clamping and
inhibition of further oligomerization is a promising approach for
the inhibition of amyloid pathology in vivo. The unique properties
of NQTrp and its remarkable activity in vitro and in vivo make it a
promising lead for the development of small molecule inhibitors of
oligomerization for the treatment of AD.
Materials and Methods
Compounds
1,4-naphthoquinon-2-yl-L-tryptophan (NQTrp) was synthe-
sized from L-tryptophan and 1,4-naphthoquione by a one step
synthesis according to the protocol by Shrestha-Dawadi et al. [39].
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1H-NMR (DMSO-d6): d= 3.3 (m, CH2), 3.9 (m, CH2), 5.6 (s,1H),
6.8 (t, J = 3.3Hz, 1H), 6.8 (t, J = 7.4Hz,1H), 7.1 (s, 1H), 7.2 (br m,
NH), 7.3 (d, J = 8.0 Hz, 1H), 7.4 (d, J = 7.5 Hz, 1H), 7.6–7.9 (m,
4H), 10.8 (NH). Reverse phase HPLC showed .95% purity.
Synthetic Ab1–42, Ab1–40 and Ab12–28 were purchased from
Bachem, (Bubendorf, Switzerland).
Figure 9. Effect of NQTrp on Ab in larvae brains. A. Head extract from 6 days old Abarc1-42-expressing flies unfed (left) and fed (right) with
0.75 mg/mL NQTrp (N = 25 in each group). Accumulation of Ab tetramers is evident only in Abarc1-42 flies which were not fed with NQTrp. (B–G)
Immuno-staining of 3rd instar larval brains with specific Ab antibody 6E10. (B, C) Control animals not expressing any Ab (elav-GAL4/+; +/+). (D, E)
Abarc1-42-expressing animals fed with regular fly food. (F, G) Abarc1-42-expressing animals fed with NQTrp (elav-GAL4/+; UAS-Abarc1-42/+). N = 10 for
each class examined. HB – hemi-brain; VNC – ventral nerve cord. Arrows indicate Ab accumulation.
doi:10.1371/journal.pone.0011101.g009
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Determination of soluble oligomer formation
Ab intermediates and toxic oligomers were produced according
to Barghorn and coworkers [15]. To avoid pre-aggregation,
synthetic lyophilized Ab1–42 was pretreated with HFIP. Ab1–42 was
dissolved in 100% HFIP, sonicated for 20 seconds and incubated
for 2 hours at 37uC under shaking at 100 RPM. NQTrp was
dissolved in DMSO to a concentration of 30 mM, sonicated for
1 min and then diluted with DMSO to its final concentrations.
After evaporation in a speedVac, Ab1–42 was resuspended in
DMSO (with or without NQTrp) to 5 mM and diluted with
20 mM NaH2PO4, 140 mM NaCl, pH 7.4 to a final concentra-
tion of 400 mM and 1/10 volume 2% SDS (final concentration of
0.2%). The toxic Ab oligomers were generated by further dilution
with two volumes of H2O and incubated for additional 18 hours
or more (for the toxic oligomer stability assay). Ab aggregation
products were then separated using a 15% tris-tricine gel and
stained using Imperial protein stain.
Fluorescence anisotropy studies
NQTrp was dissolved in DMSO to a concentration of 50 nM
and sonicated for 5 min. The solution was immediately mixed
with aliquots of an Ab1–42 intermediate (as described above) stock
solution (20 mM) to varying final polypeptide concentrations.
NQTrp polarization measurements were carried out using an ISS
K2 fluorimeter. The solutions were excited at 280 nm and
emission was monitored at 350 nm. For each single point, at least
five measurements were collected and their average values were
used for the calculation. All experiments were performed in
phosphate-buffered saline, PBS [100 mM NaCl (pH 7.4)].
ThT kinetic binding fluorescence
Synthetic lyophilized Ab1–40 was dissolved in DMSO to a
concentration of 100 mM and sonicated for 1 min to prevent pre-
aggregation. Ab solutions were prepared by immediate dilution
with 10 mM PBS [100 mM NaCl and 0.5 mM EDTA (pH 7.4)]
to a final concentration of 10 mM [containing 10% (v/v) DMSO].
The samples were diluted again to a final concentration of 5mM
with the appropriate inhibitor concentration or with PBS for
control samples. The samples were incubated at 37uC, and the
rate of fibril formation was monitored using ThT fluorescence
analysis over the course of 270 hours. The respective excitation
and emission wavelengths were 450 nm (2.5 nm slit) and 480 nm
(5 nm slit), respectively. A 10-fold diluted sample was taken and
mixed with 900 mL of 0.4 mM ThT. The fluorescence of ThT was
measured using a Jobin Yvon Horiba Fluoromax 3 fluorimeter.
Each experiment was repeated in quadruplicates.
IC50 ThT measurements
Synthetic lyophilized Ab1–42 was dissolved in DMSO to a
concentration of 100 mM and sonicated for 1 min to prevent pre-
aggregation. Ab solutions were prepared by immediate dilution
with 10 mM PBS. The samples were again diluted to a final
concentration of 5 mM with the appropriate inhibitor concentra-
tion or with PBS for control samples. ThT fluorescence was
measured after 24 hours. The respective excitation and emission
wavelengths were 450 nm (2.5 nm slit) and 480 nm (5 nm slit). A
10-fold diluted sample was taken and mixed with 900 mL of
0.4 mM ThT. The fluorescence of ThT was measured using a
Jobin Yvon Horiba Fluoromax 3 fluorimeter. Each experiment
was repeated in quadruplicates.
Transmission electron microscopy
Samples of Ab were taken after 7 days and at the end of the
ThT kinetic experiment and placed on a 400 mesh copper grid
covered by carbon-stabilized Formvar film (SPI Supplies, West
Chester, PA). The sample was allowed to stand for 1.5 min, excess
fluid was removed and the grids were negatively stained for 2 min
with 10 mL of a 2% uranyl acetate solution. Excess fluid was
removed, and the samples were viewed using a JEOL 1200EX
electron microscope operating at 80 kV.
NMR Analysis
Sample preparation. 1.06 mg of lyophilized Ab12–28 [was
dissolved in d6-DMSO to which TDW with 0.02% w/v NaN3
Figure 10. Effect of NQTrp on Ab in drosophila brains. Immuno-staining of two-day old adult fly brains with specific Ab antibody 6E10. (A–D)
Abarc1-42-expressing animals fed with regular fly food (elav-GAL4/+; UAS-Abarc1-42/+). (C, D) Enlarged images of the boxed region. (E–H) Abarc1-42-
expressing animals fed with NQTrp (elav-GAL4/+; UAS-Abarc1-42/+) (G, H) Enlarged images of the boxed region. N = 6 for each class examined.
doi:10.1371/journal.pone.0011101.g010
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was added to obtain a final sample of 1.13 mM peptide in 20%
d6-DMSO solution. The order of dissolving the peptide is essential
to achieve solubility.
NMR measurement. NQTrp was titrated into the Ab12–28
sample in 10 mL aliquots in the same solvent batch as the peptide
samples to achieve increments of 0.11 mM of NQTrp
concentration per aliquot. After each addition the 1H-NMR
spectrum was taken at 600 MHz with 16 scans at 21uC. Chemical
shift assignment was taken from [31]; K16 and G25 were
unresolved in the one-dimensional spectrum (designated by an
asterisk in Fig 3A). The difference between each amide proton
chemical shift and that of the peptide in the presence of with
0.1 mM NQTrp was determined for each subsequent aliquot.
This value was chosen to see the effect of increasing NQTrp
concentration.
Structural studies were done on the final sample from the above
under the same conditions. NMR experiments were performed on
a Bruker Avance 600 MHz DMX spectrometer operating at the
proton frequency of 600.13 MHz, using a 5-mm selective probe
equipped with a self-shielded xyz-gradient coil. The transmitter
frequency was set on the hydrogen-deuterium exchange in water
signal, which was calibrated at 4.811 ppm. Correlation spectros-
copy (COSY) [54], total correlation spectroscopy (TOCSY), using
the MLEV-17 pulse scheme for the spin lock [55], and nuclear
Overhauser effect spectroscopy [56] experiments were acquired
under identical conditions for all samples, using gradients for water
saturation. The nuclear Overhauser effect spectroscopy experi-
ments were acquired with a mixing time of 200 ms.
Spectra were processed and analyzed with the XWINNMR
(Bruker Analytische Messtechnik GmbH) and SPARKY3 soft-
ware. Resonance assignment followed the sequential assignment
methodology developed by Wu¨thrich [57]. Stereospecificity was
introduced according to the set which gave the lowest energies and
RMSDs.
Electrostatic free energies were derived from finite difference
solutions of the Poisson-Boltzman equation using the DelPhi
program [58]. The AMBER forcefield [59] was employed and a
full Coulombic calculation was performed. The positive and
negative 2 kT/e isopotential surfaces were presented using [60].
CD analysis
To avoid pre-aggregation, synthetic lyophilized Ab1–42 was
pretreated with HFIP. Ab1–42 was dissolved in 100% HFIP,
sonicated for 20 seconds and incubated for 2 hours at 37uC under
shaking at 100 RPM. NQTrp was dissolved in DMSO to a
concentration of 30 mM, sonicated for 1 min and then diluted
with H20 to its final concentrations. After evaporation in a
speedVac, Ab1–42 was resuspended in H20 (with or without
NQTrp) to 5 mM and diluted with 20 mM NaH2PO4, 140 mM
NaCl, pH 7.4 to a final concentration of 400 mM and 1/10
volume 2% SDS (final concentration of 0.2%). The toxic Ab
oligomers were generated by further dilution with two volumes of
H2O and incubated for additional 18 hours or more (for the toxic
oligomer stability assay). CD measurements were conducted using
quartz cuvette 0.1 mm path length, at 25uC, using AVIV 202 CD
spectrometer.
Simulation protocol and analysis
The molecular dynamics simulations were performed with the
CHARMM program [61,62]. The peptides and compound were
modeled using the united atoms CHARMM PARAM19 force
field with its default truncation scheme for nonbonding interac-
tions (cutoff of 7.5 A˚). Hydration effects were accounted for by
using SASA, a solvent-accessible surface based implicit model
[63]. Partial charges for NQTrp were computed with the modified
partial equalization of orbital electronegativity algorithm
(MPEOE) [64,65]. The simulation box was prepared using the
same protocol of Convertino et al. [39], having three mono-
dispersed replicas of the same heptapeptide with or without the
presence of a single NQTrp molecule. The concentration ratio
peptide:compound was 3:1. Simulations were carried out with
periodic boundary conditions at fixed peptide concentration of
5 mg/ml (the simulation box side was set to 98, 96 and 95 A˚ for
Ab14–20, Ab16–22, and Ab18–24, respectively), using Langevin
integrator at low friction constant (0.15 ps) and at a temperature
of 330 K, which yields reversible aggregation within a reasonable
computational time. For each system, ten indipendent MD runs
out of 2.5 ms each were carried out using different random number
generators for the assignment of the velocities. A 2.5 ms run takes
three weeks on a single AMD Opteron 252 CPU at 2.6 GHz.
Order parameters are useful quantities to monitor the structural
transition within peptide oligomers [46]. In particular, the nematic
order parameter allows one to measure the amount of ordered b-
structure in the system:
P2~
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The unit vector d^, that defines a preferential direction, is the
eigenvector of the order matrix that corresponds to the largest
positive eigenvalue. The N molecular unit vectors z^i are built
joining the Ca atom of residue i to the Ca atom of residue i+2
(N = 367). The values, ranging from zero to one, correspond to
complete disorder and complete order respectively. The complete
order is achieved when all the unit vectors are parallel or
antiparallel, while the disorder is obtained when none of unit
vectors is parallel to any of the others.
The threshold P2
* is a value of the order parameter chosen such
that it separates the ordered from the disordered phase, and was
chosen as P2
* = 0.665 [39]. Thus, the order-disorder ratio r is
defined by the number of events where the system has a nematic
order parameter lower than P2
* (disorder) and greater that
P2
*(order):
r~
n(P2wP2)
n(P2vP2)
ð1Þ
Furthermore, the interference of NQTrp is measured by
calculating the inter-peptide interaction energy, which is the
CHARMM non-bond energy (van der Waals plus electrostatics) of
a given peptide with the other two, without considering the
interactions with NQTrp (Figure 5). The van der Waals
interactions between NQTrp and individual Ab residues
(Figure 6) are estimated by averaging over all trajectories and
neglecting the snapshots in which the interaction with all residues
is zero. The criteria for hydrogen bond are the H-O distance
smaller than 2.5 A˚ and a NH-O angle larger than 130 degrees.
Correlation between hydrogen bond pairs is calculated using
the following formula:
Cij~
1
T
X
t
di(t)dj(t)
where i and j are hydrogen bond indexes, T is the total number of
frames in the simulation, and is one when the hydrogen bond i is
formed at time t, and zero otherwise.
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The binding modes depicted in Figure 6 were determined by
selecting the simultaneous and most frequent hydrogen bonds
between the peptide backbone and NQTrp (see Table S4). Single
peptide conformations that interact with NQTrp through the
selected hydrogen bonds were extracted. Resulting snapshots were
clustered by using an algorithm from Dr. M. Scha¨fer (Michael
Scha¨fer, Syngenta Crop Protection AG, unpublished work) with a
cutoff of 1.5 A˚ and selecting peptide heavy atoms close to NQTrp
and excluding symmetrical atoms.
Cell cytotoxicity assays
PC12 neuronal cells (26105 cells/mL) were cultured in 96-well
micro plates (100 mL/well) and incubated overnight at 37uC. To
each well we added 100 mL of 5 mM Ab toxic oligomers and
inhibitors at various concentrations. Each experiment was
repeated four times. Following incubation for 24 hours at 37uC,
cell viability was evaluated using the MTT assay. Briefly, 20 mL of
5 mg/mL MTT dissolved in PBS were added to each well. After
4 hours of incubation at 37uC, 100 mL of extraction buffer [20%
SDS dissolved in a solution of 50% dimethylformamide and 50%
DDW (pH 4.7)] were added to each well, and the plates were
incubated again overnight at 37uC. Finally, color intensity was
measured using an ELISA reader at 570 nm.
Fly keeping
Flies were reared on standard corneal-molasses medium and
were kept at 25uC. As Drosophila females can store sperm cells in
their bodies, crosses were conducted using virgin females collected
no longer than 8 hours after eclosion at 25uC or 18 hours after
eclosion at 18uC. Adult offspring (F1) from the crosses were
collected up to 9 days after the beginning of their eclosion at 25uC
in order to avoid offspring from the next generation (F2).
Fly crossing
Male flies carrying the driver elavc155-Gal4 (on their X
chromosome) were crossed to females carrying the Ab1–42
transgene (located on an autosome) under the UAS promoter in
a homozygous condition. This resulted in first generation (F1)
female offspring expressing Ab1–42 in their nervous system. They
served as our Alzheimer’s Drosophila model. Male F1 offspring,
which carried the Ab1–42 trasgene but did not express it (because
they lacked the Gal4 driver) served as a control. Animals
expressing Abarc1-42 were generated in a similar way.
Fly feeding
NQTrp was added to standard corneal-molasses medium about
10 minutes after cooking (0.75 mg/mL). The compound was mixed
thoroughly into the medium and the mixture was aliquoted into
rearing vials. The vials were kept at 4uC until use. Crosses were
performed either on regular Drosophila medium (control) or on
medium supplemented with NQTrp. Animals fed on the appropri-
ate medium from the beginning of the larval stage onwards. Animals
expressing Abarc1-42 were generated and assayed in a similar way.
Longetivity assay
Flies expressing one copy of Ab1–42 reared at 29uC on medium
with and without NQTrp were classified into four classes: 1.
Females expressing Ab1–42, on regular medium. 2. Females
expressing Ab1–42, on medium supplemented with NQTrp. 3.
Male controls (lacking the Gal4 driver), on regular medium. 4.
Male controls (lacking the Gal4 driver), on medium supplemented
with NQTrp. For each class, six vials each with 10 flies were
collected and fresh food was provided every three days (whether
with or without NQTrp). The number of viable Ab-expressing and
control flies treated with and without NQTrp was recorded daily
post eclosion. Differences in survival rates were analyzed using the
SPSS 11 Kaplan-Meir software package. Animals expressing
Abarc1-42 were generated and assayed in a similar way. The
longetivity assay was repeated three times. All three analyses
showed similar results.
Locomotive (climbing) assay
Test tubes of each of the four classes mentioned above, each
containing 10 flies, were tapped gently on the table and were let
stand for 18 seconds. The percent of flies which climbed to the top
of the test tube was then calculated over time [50,51]. Each class
had six independent vial-repeats. Statistical analysis was done
using StatSoft Statistica 7, parametric ANOVA testing. The
locomotive assay was repeated three times. All three analysis
showed similar results.
Immuno-precipitation and western-blot of fly head
extracts
Twenty five freshly decapitated heads from 6 day old Abarc1-42
flies treated and non-treated with NQTrp were collected and
homogenized in 30 ml PBS/protease inhibitor/ 1% SDS following
[46]. Homogenates were then centrifuged at 13000 rpm for
25 seconds and the supernatant was further immuno-precipitated
with specific 6E10 anti-Ab antibody (1:10) over night at 4uC.
Boiled samples were then western blotted and membranes were
boiled in PBS for 10 minutes before antibodies were introduced.
Total protein levels of the samples were quantified using Bradford
analysis prior to gel loading. Since samples were loaded after IP
with specific 6E10 anti-Ab antibody, no marker protein levels
could be measured.
Immuno-staining of larval brains
3rd instar larvae were dissected and stained using the following
antibodies: primary 6E10 antibody (1:250) and secondary
biotinylated anti-mouse antibody detected with Vecta-Stain-Elite
ABC-HRP kit (Vector Laboratories). Stained larvae brains were
mounted in 70% glycerol, 30% Tris pH 7.6 and viewed using
bright-field microscopy (Nikon, Eclipse E600).
Immuno-staining of adult fly brains
Two-day old adult flies were dissected and their brains were
removed. Whole brains were stained using the following
antibodies: primary 6E10 antibody (1:250) and secondary anti-
mouse Cy3 (1:100). Stained whole brains were imaged using
confocal microscopy (LSM 510).
Supporting Information
Figure S1 Structure of naphthoquione-based molecules
screened for inhibition of Ab assembly. Compounds IL and IID
are L and D isomers of NQTrp.
Found at: doi:10.1371/journal.pone.0011101.s001 (0.04 MB
DOC)
Figure S2 1H-NMR spectra. Fingerprint regions of TOCSY
(greens) spectrum overlaid on NOESY (reds) spectrum of Ab12–28
with NQTrp (4:1 molar ratio) with assignment.
Found at: doi:10.1371/journal.pone.0011101.s002 (0.23 MB
DOC)
Figure S3 1H-NMR derived structures. Ensemble of nine low
energy structures generated for Ab12–28 with NQTrp (4:1 molar
ratio).
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Found at: doi:10.1371/journal.pone.0011101.s003 (0.08 MB
DOC)
Figure S4 Hydrogen bonds frequency between NQTrp and Ab
peptide backbone: For polar group labeling refer to the inset of
Figure 5.
Found at: doi:10.1371/journal.pone.0011101.s004 (0.05 MB
DOC)
Figure S5 Cytotoxicity analysis of NQTrp: PC12 cell line was
incubated with different concentrations of NQTrp. The cytotoxic
effect of NQTrp was determined using the MTT assay. Control -
no NQTrp.
Found at: doi:10.1371/journal.pone.0011101.s005 (0.03 MB
DOC)
Table S1 Summary of Ab inhibition by all molecules examined:
Twelve naphthoquione-based molecules were analyzed for
inhibition of both oligomer and fibril formation. The relative
degree of inhibition is indicated. No inhibition (2), low inhibition
(+), moderate inhibition (++), significant inhibition (+++).
Found at: doi:10.1371/journal.pone.0011101.s006 (0.03 MB
DOC)
Table S2 Neo constraints.
Found at: doi:10.1371/journal.pone.0011101.s007 (0.05 MB
DOC)
Table S3 Average number of hydrogen bonds: aAverage
number of inter- and intra-peptide backbone-backbone hydrogen
bonds, with (+) and without (2) NQTrp. The standard deviation is
evaluated on ten independent simulations. bRatio between order
and disorder events sampled in the simulations.
Found at: doi:10.1371/journal.pone.0011101.s008 (0.05 MB
DOC)
Table S4 Hydrogen bond correlations: Correlation among pair
of hydrogen bonds between individual polar groups of NQTrp
and the peptide backbone. The pairs occurring more frequently
are reported in bold. The naming convention of the polar groups
of NQTrp is as Fig. 6.
Found at: doi:10.1371/journal.pone.0011101.s009 (0.11 MB
DOC)
Table S5 Highest probability hydrogen bonds: Pairs of hydro-
gen bonds with the highest probability (.0.01) to be simulta-
neously formed. The naming convention of the polar groups of
NQTrp is as Fig. 2 bottom.
Found at: doi:10.1371/journal.pone.0011101.s010 (0.06 MB
DOC)
Table S6 IC50 of aromatic inhibitors of Ab.
Found at: doi:10.1371/journal.pone.0011101.s011 (0.03 MB
DOC)
References S1 References for table S6.
Found at: doi:10.1371/journal.pone.0011101.s012 (0.02 MB
DOC)
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